Autoimmune BSEP Disease: Disease Recurrence After Liver Transplantation for Progressive Familial Intrahepatic Cholestasis

Clinical Reviews in Allergy and Immunology

Volumn 48, Issue 2-3, 2015, Pages 273-284

  Kubitz, Ralf ^a,b   Dröge, Carola ^a   Kluge, Stefanie ^a   Stross, Claudia ^a   Walter, Nathalie ^a   Keitel, Verena ^a   Häussinger, Dieter ^a   Stindt, Jan ^a  

^a Department of Orthopedic Surgery   (Germany)

^b Krankenhaus Bethanien   (Germany)

Author keywords

Autoimmune disease; Autoreactive antibodies; Bile salt export pump; BSEP; PFIC 2

Indexed keywords

ABC TRANSPORTER; ABCB11 PROTEIN, HUMAN; AUTOANTIBODY; MULTIDRUG RESISTANCE PROTEIN;

AUTOIMMUNE DISEASE; CHOLESTASIS, INTRAHEPATIC; DEFICIENCY; DISEASE COURSE; GENETICS; HUMAN; IMMUNOLOGY; LIVER TRANSPLANTATION; METABOLISM; RECURRENT DISEASE; SEVERITY OF ILLNESS INDEX;

ATP-BINDING CASSETTE TRANSPORTERS; AUTOANTIBODIES; AUTOIMMUNE DISEASES; CHOLESTASIS, INTRAHEPATIC; DISEASE PROGRESSION; HUMANS; LIVER TRANSPLANTATION; P-GLYCOPROTEINS; RECURRENCE; SEVERITY OF ILLNESS INDEX;

EID: 84937546595     PISSN: 10800549     EISSN: 15590267     Source Type: Journal    
DOI: 10.1007/s12016-014-8457-4     Document Type: Review

References (85)

1. Davit-Spraul A, Gonzales E, Baussan C, Jacquemin E (2009) Progressive familial intrahepatic cholestasis. Orphanet J Rare Dis 4:1
2. Strautnieks SS, Byrne JA, Pawlikowska L et al (2008) Severe bile salt export pump deficiency: 82 different ABCB11 mutations in 109 families. Gastroenterology 134:1203–1214
3. Aydogdu S, Cakir M, Arikan C et al (2007) Liver transplantation for progressive familial intrahepatic cholestasis: clinical and histopathological findings, outcome and impact on growth. Pediatr Transplant 11:634–640
4. Jacquemin E (2000) Progressive familial intrahepatic cholestasis. Genetic basis and treatment. Clin Liver Dis 4:753–763
5. Jacquemin E (2012) Progressive familial intrahepatic cholestasis. Clin Res Hepatol Gastroenterol 36(Suppl 1):S26–S35
6. Paulusma CC, Groen A, Kunne C et al (2006) Atp8b1 deficiency in mice reduces resistance of the canalicular membrane to hydrophobic bile salts and impairs bile salt transport. Hepatology 44:195–204
7. Bull LN, van Eijk MJ, Pawlikowska L et al (1998) A gene encoding a P-type ATPase mutated in two forms of hereditary cholestasis. Nat Genet 18:219–224
8. Strautnieks SS, Bull LN, Knisely AS et al (1998) A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis. Nat Genet 20:233–238
9. Gerloff T, Stieger B, Hagenbuch B et al (1998) The sister of P-glycoprotein represents the canalicular bile salt export pump of mammalian liver. J Biol Chem 273:10046–10050
10. Kubitz R, Dröge C, Stindt J, Weissenberger K, Häussinger D (2012) The bile salt export pump (BSEP) in health and disease. Clin Res Hepatol Gastroenterol 36:536–553
11. Davit-Spraul A, Fabre M, Branchereau S et al (2010) ATP8B1 and ABCB11 analysis in 62 children with normal gamma-glutamyl transferase progressive familial intrahepatic cholestasis (PFIC): phenotypic differences between PFIC1 and PFIC2 and natural history. Hepatology 51:1645–1655
12. Morotti RA, Suchy FJ, Magid MS (2011) Progressive familial intrahepatic cholestasis (PFIC) type 1, 2, and 3: a review of the liver pathology findings. Semin Liver Dis 31:3–10
13. Knisely AS, Strautnieks SS, Meier Y et al (2006) Hepatocellular carcinoma in ten children under five years of age with bile salt export pump deficiency. Hepatology 44:478–486
14. Sheridan R.M., Gupta A., Miethke A., Knisely A.S. and Bove K.E. (2012) Multiple dysplastic liver nodules in PFIC2 underscore risk for neoplasia associated with functional BSEP deficiency. Am.J.Surg.Pathol
15. Knisely AS (2000) Progressive familial intrahepatic cholestasis: a personal perspective. Pediatr Dev Pathol 3:113–125
16. Byrne JA, Strautnieks SS, Ihrke G et al (2009) Missense mutations and single nucleotide polymorphisms in ABCB11 impair bile salt export pump processing and function or disrupt pre-messenger RNA splicing. Hepatology 49:553–567
17. Faust TW (2000) Recurrent primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis after transplantation. Semin Liver Dis 20:481–495
18. Mieli-Vergani G, Vergani D (2011) Autoimmune liver diseases in children—what is different from adulthood? Best Pract Res Clin Gastroenterol 25:783–795
19. Mieli-Vergani G, Vergani D (2013) Paediatric autoimmune liver disease. Arch Dis Child 98:1012–1017
20. Richter A, Grabhorn E, Helmke K, Manns MP, Ganschow R, Burdelski M (2007) Clinical relevance of autoantibodies after pediatric liver transplantation. Clin Transplant 21:427–432
21. Liberal R, Zen Y, Mieli-Vergani G, Vergani D (2013) Liver transplantation and autoimmune liver diseases. Liver Transpl 19:1065–1077
22. Keitel V, Burdelski M, Vojnisek Z, Schmitt L, Häussinger D, Kubitz R (2009) De novo bile salt transporter antibodies as a possible cause of recurrent graft failure after liver transplantation: a novel mechanism of cholestasis. Hepatology 50:510–517
23. Jara P, Hierro L, Martinez-Fernandez P (2009) Recurrence of bile salt export pump deficiency after liver transplantation. N Engl J Med 361:1359–1367
24. Noe J, Kullak-Ublick GA, Jochum W et al (2005) Impaired expression and function of the bile salt export pump due to three novel ABCB11 mutations in intrahepatic cholestasis. J Hepatol 43:536–543
25. Stindt J, Ellinger P, Weissenberger K et al (2013) A novel mutation within a transmembrane helix of the bile salt export pump (BSEP, ABCB11) with delayed development of cirrhosis. Liver Int 33:1527–1535
26. Jansen PL, Strautnieks SS, Jacquemin E et al (1999) Hepatocanalicular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasis. Gastroenterology 117:1370–1379
27. Keitel V, Burdelski M, Warskulat U et al (2005) Expression and localization of hepatobiliary transport proteins in progressive familial intrahepatic cholestasis. Hepatology 41:1160–1172
28. Wang L, Dong H, Soroka CJ, Wei N, Boyer JL, Hochstrasser M (2008) Degradation of the bile salt export pump at endoplasmic reticulum in progressive familial intrahepatic cholestasis type II. Hepatology 48:1558–1569
29. Hayashi H, Takada T, Suzuki H, Akita H, Sugiyama Y (2005) Two common PFIC2 mutations are associated with the impaired membrane trafficking of BSEP/ABCB11. Hepatology 41:916–924
30. Kubitz R, Sütfels G, Kühlkamp T, Kölling R, Häussinger D (2004) Trafficking of the bile salt export pump from the Golgi to the canalicular membrane is regulated by the p38 MAP kinase. Gastroenterology 126:541–553
31. Chan W, Calderon G, Swift AL et al (2005) Myosin II regulatory light chain is required for trafficking of bile salt export protein to the apical membrane in Madin-Darby canine kidney cells. J Biol Chem 280:23741–23747
32. Wang L, Soroka CJ, Boyer JL (2002) The role of bile salt export pump mutations in progressive familial intrahepatic cholestasis type II. J Clin Invest 110:965–972
33. Mochizuki K, Kagawa T, Numari A et al (2007) Two N-linked glycans are required to maintain the transport activity of the bile salt export pump (ABCB11) in MDCK II cells. Am J Physiol Gastrointest Liver Physiol 292:G818–G828
34. Crocenzi FA, Sanchez Pozzi EJ, Ruiz ML et al (2008) Ca(2+)-dependent protein kinase C isoforms are critical to estradiol 17beta-D-glucuronide-induced cholestasis in the rat. Hepatology 48:1885–1895
35. Kubitz R, Saha N, Kühlkamp T et al (2004) Ca2+-dependent protein kinase C isoforms induce cholestasis in rat liver. J Biol Chem 279:10323–10330
36. Cantore M, Reinehr R, Sommerfeld A, Becker M, Häussinger D (2011) The Src family kinase Fyn mediates hyperosmolarity-induced Mrp2 and Bsep retrieval from canalicular membrane. J Biol Chem 286:45014–45029
37. Dombrowski F, Stieger B, Beuers U (2006) Tauroursodeoxycholic acid inserts the bile salt export pump into canalicular membranes of cholestatic rat liver. Lab Invest 86:166–174
38. Kubitz R, Keitel V, Scheuring S, Köhrer K, Häussinger D (2006) Benign recurrent intrahepatic cholestasis associated with mutations of the bile salt export pump. J Clin Gastroenterol 40:171–175
39. van Mil SW, Van Der Woerd WL, Van Der BG et al (2004) Benign recurrent intrahepatic cholestasis type 2 is caused by mutations in ABCB11. Gastroenterology 127:379–384
40. Dixon PH, Van MS, Chambers J (2009) Contribution of variant alleles of ABCB11 to susceptibility to intrahepatic cholestasis of pregnancy. Gut 58:537–544
41. Dixon PH, Wadsworth CA, Chambers J et al (2014) A comprehensive analysis of common genetic variation around six candidate loci for intrahepatic cholestasis of pregnancy. Am J Gastroenterol 109:76–84
42. Dawson S, Stahl S, Paul N, Barber J, Kenna JG (2012) In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans. Drug Metab Dispos 40:130–138
43. Morgan RE, Trauner M, van Staden CJ et al (2010) Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development. Toxicol Sci 118:485–500
44. Ogimura E, Sekine S, Horie T (2011) Bile salt export pump inhibitors are associated with bile acid-dependent drug-induced toxicity in sandwich-cultured hepatocytes. Biochem Biophys Res Commun 416:313–317
45. Lam P, Pearson CL, Soroka CJ, Xu S, Mennone A, Boyer JL (2007) Levels of plasma membrane expression in progressive and benign mutations of the bile salt export pump (Bsep/Abcb11) correlate with severity of cholestatic diseases. Am J Physiol Cell Physiol 293:C1709–C1716
46. Englert C, Grabhorn E, Richter A, Rogiers X, Burdelski M, Ganschow R (2007) Liver transplantation in children with progressive familial intrahepatic cholestasis. Transplantation 84:1361–1363
47. Hayashi H, Sugiyama Y (2007) 4-phenylbutyrate enhances the cell surface expression and the transport capacity of wild-type and mutated bile salt export pumps. Hepatology 45:1506–1516
48. Emerick KM, Elias MS, Melin-Aldana H (2008) Bile composition in Alagille Syndrome and PFIC patients having Partial External Biliary Diversion. BMC Gastroenterol 8:47
49. Kurbegov AC, Setchell KD, Haas JE et al (2003) Biliary diversion for progressive familial intrahepatic cholestasis: improved liver morphology and bile acid profile. Gastroenterology 125:1227–1234
50. Alissa FT, Jaffe R, Shneider BL (2008) Update on progressive familial intrahepatic cholestasis. J Pediatr Gastroenterol Nutr 46:241–252
51. Moreira RK, Salomao M, Verna EC, Brown RS Jr, Lefkowitch JH (2013) The Hepatitis Aggressiveness Score (HAS): a novel classification system for post-liver transplantation recurrent hepatitis C. Am J Surg Pathol 37:104–113
52. Verna EC, Abdelmessih R, Salomao MA, Lefkowitch J, Moreira RK, Brown RS Jr (2013) Cholestatic hepatitis C following liver transplantation: an outcome-based histological definition, clinical predictors, and prognosis. Liver Transpl 19:78–88
53. Tamura S, Sugawara Y, Kaneko J et al (2008) Recurrence of cholestatic liver disease after living donor liver transplantation. World J Gastroenterol 14:5105–5109
54. Liermann Garcia RF, Evangelista GC, McMaster P, Neuberger J (2001) Transplantation for primary biliary cirrhosis: retrospective analysis of 400 patients in a single center. Hepatology 33:22–27
55. Neuberger J (2001) Recurrent primary biliary cirrhosis. Liver Transpl 7:596–599
56. Brandsaeter B, Isoniemi H, Broome U et al (2004) Liver transplantation for primary sclerosing cholangitis; predictors and consequences of hepatobiliary malignancy. J Hepatol 40:815–822
57. Graziadei IW (2002) Recurrence of primary sclerosing cholangitis after liver transplantation. Liver Transpl 8:575–581
58. Khettry U, Keaveny A, Goldar-Najafi A et al (2003) Liver transplantation for primary sclerosing cholangitis: a long-term clinicopathologic study. Hum Pathol 34:1127–1136
59. LaRusso NF, Shneider BL, Black D et al (2006) Primary sclerosing cholangitis: summary of a workshop. Hepatology 44:746–764
60. Graziadei IW (2011) Live donor liver transplantation for primary sclerosing cholangitis: is disease recurrence increased? Curr Opin Gastroenterol 27:301–305
61. Lin HC, Alvarez L, Laroche G et al (2013) Rituximab as therapy for the recurrence of bile salt export pump deficiency after liver transplantation. Liver Transpl 19:1403–1410
62. Maggiore G, Gonzales E, Sciveres M et al (2010) Relapsing features of bile salt export pump deficiency after liver transplantation in two patients with progressive familial intrahepatic cholestasis type 2. J Hepatol 53:981–986
63. Siebold L, Dick AA, Thompson R et al (2010) Recurrent low gamma-glutamyl transpeptidase cholestasis following liver transplantation for bile salt export pump (BSEP) disease (posttransplant recurrent BSEP disease). Liver Transpl 16:856–863
64. Stindt J, Kluge S, Dröge C, Keitel V, Engelmann G, Ganschow R, Knisely AS, Häussinger D, Kubitz R (2013) Acquired BSEP disease due to post-LTX auto-reactive antibody development in PFIC-2 patients. Hepatology 58(4):119A, Ref Type: Abstract
65. Burwen SJ, Schmucker DL, Jones AL (1992) Subcellular and molecular mechanisms of bile secretion. Int Rev Cytol 135:269–313
66. Jones AL, Huling S, Altorfer J (1989) Synthesis and biliary secretion of immunoglobulins by rat liver. Immunol Invest 18:299–312
67. Blumberg RS, Koss T, Story CM et al (1995) A major histocompatibility complex class I-related Fc receptor for IgG on rat hepatocytes. J Clin Invest 95:2397–2402
68. Brown WR, Kloppel TM (1989) The liver and IgA: immunological, cell biological and clinical implications. Hepatology 9:763–784
69. Delacroix DL, Hodgson HJ, McPherson A, Dive C, Vaerman JP (1982) Selective transport of polymeric immunoglobulin A in bile. Quantitative relationships of monomeric and polymeric immunoglobulin A, immunoglobulin M, and other proteins in serum, bile, and saliva. J Clin Invest 70:230–241
70. Peppard JV, Jackson LE, Hall JG (1983) The occurrence of secretory IgM in the bile of rats. Clin Exp Immunol 53:623–626
71. Telleman P, Junghans RP (2000) The role of the Brambell receptor (FcRB) in liver: protection of endocytosed immunoglobulin G (IgG) from catabolism in hepatocytes rather than transport of IgG to bile. Immunology 100:245–251
72. Kipp H, Arias IM (2000) Newly synthesized canalicular ABC transporters are directly targeted from the Golgi to the hepatocyte apical domain in rat liver. J Biol Chem 275:15917–15925
73. Kipp H, Arias IM (2002) Trafficking of canalicular ABC transporters in hepatocytes. Annu Rev Physiol 64:595–608
74. Soroka CJ, Pate MK, Boyer JL (1999) Canalicular export pumps traffic with polymeric immunoglobulin A receptor on the same microtubule-associated vesicle in rat liver. J Biol Chem 274:26416–26424
75. Ramnarayanan SP, Cheng CA, Bastaki M, Tuma PL (2007) Exogenous MAL reroutes selected hepatic apical proteins into the direct pathway in WIF-B cells. Mol Biol Cell 18:2707–2715
76. Collado JA, Guitart C, Ciudad MT, Alvarez I, Jaraquemada D (2013) The repertoires of peptides presented by MHC-II in the thymus and in peripheral tissue: a clue for autoimmunity? Front Immunol 4:442
77. Jansen PL, Sturm E (2003) Genetic cholestasis, causes and consequences for hepatobiliary transport. Liver Int 23:315–322
78. Leandro MJ (2013) B-cell subpopulations in humans and their differential susceptibility to depletion with anti-CD20 monoclonal antibodies. Arthritis Res Ther 15(1):S3
79. Rosman Z, Shoenfeld Y, Zandman-Goddard G (2013) Biologic therapy for autoimmune diseases: an update. BMC Med 11:88
80. Teng YK, Wheater G, Hogan VE et al (2012) Induction of long-term B-cell depletion in refractory rheumatoid arthritis patients preferentially affects autoreactive more than protective humoral immunity. Arthritis Res Ther 14:R57
81. Jungst C, Lammert F (2013) Cholestatic liver disease. Dig Dis 31:152–154
82. Pawlikowska L, Strautnieks S, Jankowska I et al (2010) Differences in presentation and progression between severe FIC1 and BSEP deficiencies. J Hepatol 53:170–178
83. Trauner M, Boyer JL (2003) Bile salt transporters: molecular characterization, function, and regulation. Physiol Rev 83:633–671
84. Van Der Woerd WL, van Mil SW, Stapelbroek JM, Klomp LW, van de Graaf SF, Houwen RH (2010) Familial cholestasis: progressive familial intrahepatic cholestasis, benign recurrent intrahepatic cholestasis and intrahepatic cholestasis of pregnancy. Best Pract Res Clin Gastroenterol 24:541–553
85. Wendum D, Barbu V, Rosmorduc O, Arrive L, Flejou JF, Poupon R (2012) Aspects of liver pathology in adult patients with MDR3/ABCB4 gene mutations. Virchows Arch 460:291–298